Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hopital Saint-Louis
Paris, France
- City of Hope National Medical Center
Duarte, California, United States
- Ucsd Medical Center
La Jolla, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- University of Florida College of Medicine (shands)
Gainesville, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Dfci/brigham & Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Washington University/barnes Jewish Hospital
St Louis, Missouri, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University Hospitals of Cleveland/case Western
Cleveland, Ohio, United States
- Ohio State, Arthur G. James Cancer Hospital
Columbus, Ohio, United States
- University of Oklahoma Medical Center
Oklahoma City, Oklahoma, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- Virginia Commonwealth University/mcv Hospital
Richmond, Virginia, United States
- University of Wisconsin Hospital & Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2006
- Primary completion
- 31 Oct 2012
- Completion
- 31 Oct 2015
- Last update posted
- 4 Jan 2023
- Registered enrollment
- 304
- Registry id
- NCT00406393
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.